| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1606 | 2018 |
| Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 1380 | 2014 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10, 1-10, 2012 | 901 | 2012 |
| BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma M Colombino, M Capone, A Lissia, A Cossu, C Rubino, V De Giorgi, ... J Clin Oncol 30 (20), 2522-2529, 2012 | 519 | 2012 |
| Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma S Scala, A Ottaiano, PA Ascierto, M Cavalli, E Simeone, P Giuliano, ... Clinical Cancer Research 11 (5), 1835-1841, 2005 | 374 | 2005 |
| Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study A Bartolazzi, F Orlandi, E Saggiorato, M Volante, F Arecco, R Rossetto, ... The lancet oncology 9 (6), 543-549, 2008 | 337 | 2008 |
| Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients F Izzo, R Thomas, P Delrio, M Rinaldo, P Vallone, A DeChiara, G Botti, ... Cancer 92 (8), 2036-2044, 2001 | 296 | 2001 |
| Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. G Viglietto, D Maglione, M Rambaldi, J Cerutti, A Romano, F Trapasso, ... Oncogene 11 (8), 1569-1579, 1995 | 295 | 1995 |
| Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma E Simeone, G Gentilcore, D Giannarelli, AM Grimaldi, C Caracò, ... Cancer immunology, immunotherapy 63, 675-683, 2014 | 263 | 2014 |
| Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients A Ottaiano, R Franco, A Aiello Talamanca, G Liguori, F Tatangelo, ... Clinical cancer research 12 (9), 2795-2803, 2006 | 247 | 2006 |
| Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients F Ginevri, A Azzi, HH Hirsch, S Basso, I Fontana, M Cioni, S Bodaghi, ... American Journal of Transplantation 7 (12), 2727-2735, 2007 | 238 | 2007 |
| In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients S Del Vecchio, A Ciarmiello, MI Potena, MV Carriero, C Mainolfi, G Botti, ... European journal of nuclear medicine 24, 150-159, 1997 | 236 | 1997 |
| Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches F Ginevri, R De Santis, P Comoli, N Pastorino, C Rossi, G Botti, I Fontana, ... Transplantation 75 (8), 1266-1270, 2003 | 213 | 2003 |
| Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (442 views) A Ciarmiello, S Del Vecchio, P Silvestro, MI Potena, MV Carriero, ... Journal Of Clinical Oncology (ISSN: 0732-183x) 16 (5), 1677-1683, 1998 | 211 | 1998 |
| Urokinase Receptor Interacts with αvβ5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer MV Carriero, SD Vecchio, M Capozzoli, P Franco, L Fontana, A Zannetti, ... Cancer research 59 (20), 5307-5314, 1999 | 189 | 1999 |
| Detection of high mobility group I HMGI (Y) protein in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma G Chiappetta, G Tallini, MC De Biasio, G Manfioletti, FJ Martinez-Tello, ... Cancer research 58 (18), 4193-4198, 1998 | 189 | 1998 |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro Genomics 102 (2), 74-83, 2013 | 177 | 2013 |
| Epithelial-mesenchymal transition in prostate cancer: an overview M Montanari, S Rossetti, C Cavaliere, C D'Aniello, MG Malzone, ... Oncotarget 8 (21), 35376, 2017 | 173 | 2017 |
| Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ … G Pannone, V Rodolico, A Santoro, L Lo Muzio, R Franco, G Botti, ... Infectious agents and cancer 7, 1-14, 2012 | 172 | 2012 |
| A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life A Chirico, F Lucidi, T Merluzzi, F Alivernini, M De Laurentiis, G Botti, ... Oncotarget 8 (22), 36800, 2017 | 166 | 2017 |
